Back
Vertex Pharmaceuticals, Inc. Vs. Biogen, Inc. Industry Stock Comparison
Buy
53
VRTX
Vertex Pharmaceuticals, Inc.
Last Price:
$459.71
Seasonality Move:
3%
Buy
51
BIIB
Biogen, Inc.
Last Price:
$176.86
Seasonality Move:
3.09%
Buy
53
Vertex Pharmaceuticals, Inc. (VRTX)
is a Buy
Is Vertex Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $459.78. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $176.83. The Score for BIIB is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals, Inc.'s stock price today?
-
The Vertex Pharmaceuticals, Inc. share price today is $459.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight selling pressure.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $176.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing selling pressure, which indicates risk of future bearish movement.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 127.69 | Buy |
| Relative Strength Index (14 RSI): | 60.48 | Buy |
| Chaikin Money Flow: | -148307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (434.05 - 459.69) | Buy |
| Bollinger Bands (100): | (390.22 - 439.32) | Buy |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 57.75 | Buy |
| Chaikin Money Flow: | -479207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (173.45 - 180.49) | Sell |
| Bollinger Bands (100): | (137.64 - 169.66) | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 457.29 | Buy |
| 20-day SMA: | 451.27 | Buy |
| 50-day SMA: | 435.38 | Buy |
| 200-day SMA: | 440.27 | Buy |
| 8-day EMA: | 397.93 | Buy |
| 20-day EMA: | 252.5 | Buy |
| 50-day EMA: | 125.36 | Buy |
| 200-day EMA: | 35.17 | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 174.57 | Buy |
| 20-day SMA: | 176.31 | Buy |
| 50-day SMA: | 166.1 | Buy |
| 200-day SMA: | 140.84 | Buy |
| 8-day EMA: | 175.56 | Buy |
| 20-day EMA: | 174.46 | Buy |
| 50-day EMA: | 167.32 | Buy |
| 200-day EMA: | 153.37 | Buy |
Vertex Pharmaceuticals, Inc. Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.96 per share, and an increase next year of $1.79 per share.
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and an increase next year of $0.18 per share.
Vertex Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||